Q4 2023 PolyPid Ltd Earnings Call Transcript
Thank you all for participating in PolyPid fourth quarter and full year 2023 earnings conference call. Joining me on the call today will be Dikla Czaczkes Akselbrad, Chief Executive Officer; PolyPid, Jonny Missulawin, PolyPid, Chief Financial Officer; and Ori Warshavsky, Chief Operating Officer of PolyPid.
Earlier today, PolyPid released financial results for the 3-months and 12-months ended December 31, 2023. A copy of the press release is available in the Investors section on the company's website, www.polypid.com.
I'd like to remind you that on this call, management will make forward-looking statements within the meaning of the Federal Securities Laws, for example, management is making forward-looking statements when it discusses the expected timing for recruitment and top-line results from the SHIELD II trial and of the unblinded interim analysis, the planned new drug application submission for D-PLEX100.
The potential impacts and uses for OncoPLEX and the PLEX
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
